| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Sep―08 |
In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS-CoV-2 main protease (Mpro) |
Merusomayajula V. Kishore, T. Siva Rao, G. N. D. Kumari |
| 2 |
[GO] |
2024―Apr―04 |
nCoV-19 therapeutics using cucurbitacin I structural derivatives: an in silico approach |
Ram Lal Swagat Shrestha, Bishnu Prasad Marasini, Jhashanath Adhikari Subin |
| 3 |
[GO] |
2023―Dez―11 |
GC-MS and ADME profile analysis of Carcinoscorpius rotundicauda bioactive compounds and their potential as COVID-19 antiviral |
Ahmad Misbakhus Sururi, Dwi Anggorowati Rahayu, Martina Kurnia Rohma, Maftukhatul Faizah, Elsa Aulia Vebianawati, Mia Savita |
| 4 |
[GO] |
2023―Okt―23 |
Rapid and validated UHPLC method for simultaneous determination of sofosbuvir, ledipasvir and paracetamol as commonly repurposed drugs for COVID-19 treatment: application in spiked human plasma |
Sherif Gamal, Gehad G. Mohamed, Said A. Salih, Menna I. Ezzeldin, Asmaa A. Mandour |
| 5 |
[GO] |
2023―Aug―16 |
Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment |
Sherif Gamal, Asmaa A. Mandour, Gehad G. Mohamed, Said A. Salih, Dina A. Ahmed |
| 6 |
[GO] |
2023―Aug―01 |
In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics |
Rahatul Islam, Asif Shahriar, Nour Fatema, Muhammad Ramiz Uddin, Mrityunjoy Acharjee, Md Mukhlesur Rahman Shepon, Avishek Sarkar, Khosnur Jahan Aurin |
| 7 |
[GO] |
2022―Jun―21 |
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro) |
Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar |
| 8 |
[GO] |
2022―Mrz―28 |
Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies |
Chinonyerem O. Iheanacho, Uchenna I. H. Eze |
| 9 |
[GO] |
2021―Okt―10 |
Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2 |
James H. Zothantluanga, Neelutpal Gogoi, Anshul Shakya, Dipak Chetia, H. Lalthanzara |
| 10 |
[GO] |
2021―Sep―06 |
Computational approach towards the design of artemisinin-thymoquinone hybrids against main protease of SARS-COV-2 |
Victor Moreira de Oliveira, Matheus Nunes da Rocha, Emanuel Paula Magalhães, Francisco Rogênio da Silva Mendes, Márcia Machado Marinho, Ramon Róseo Paula Pessoa Bezerra de Menezes, Tiago Lima Sampaio, Hélcio Silva dos Santos, Alice Maria Costa Martins, Emmanuel Silva Marinho |
| 11 |
[GO] |
2021―Aug―10 |
Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach |
Abd. Kakhar Umar |
| 12 |
[GO] |
2021―Jun―15 |
Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2 |
Nazim Uddin Emon, Md. Munsur Alam, Irin Akter, Saima Akhter, Anjuman Ara Sneha, Md. Irtiza, Marufa Afroj, Arifa Munni, Masruba Hossen Chowdhury, Summiya Hossain |
| 13 |
[GO] |
2021―Jun―12 |
Substantial effect of phytochemical constituents against the pandemic disease influenza-a review |
A. Brindha Devi, R. Sarala |
| 14 |
[GO] |
2021―Jun―11 |
A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future |
Saad Ahmed Sami, Kay Kay Shain Marma, Agnila Chakraborty, Tandra Singha, Ahmed Rakib, Md. Giash Uddin, Mohammed Kamrul Hossain, S. M. Naim Uddin |
| 15 |
[GO] |
2021―Jun―02 |
Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review |
C. S. Sharanya, A. Sabu, M. Haridas |
| 16 |
[GO] |
2021―Apr―09 |
Present and future treatment strategies for coronavirus disease 2019 |
Engy Elekhnawy, Amal Abo Kamar, Fatma Sonbol |
| 17 |
[GO] |
2021―Mrz―24 |
Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review |
Chinonyerem O. Iheanacho, Valentine U. Odili, Uchenna I. H. Eze |
| 18 |
[GO] |
2021―Mrz―20 |
Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019 |
Olutayo Ademola Adeleye, Mbang Nyong Femi-Oyewo, Oluyemisi Adebowale Bamiro, Lateef Gbenga Bakre, Akinyinka Alabi, Joseph Senu Ashidi, Olalekan Adeyinka Balogun-Agbaje, Oluwakemi Mary Hassan, Gbemisola Fakoya |
| 19 |
[GO] |
2021―Mrz―17 |
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials |
Reshma Raju, Prajith V., Pratheeksha Sojan Biatris, Sam Johnson Udaya Chander J. |
| 20 |
[GO] |
2021―Jan―09 |
Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda |
M. Haridas, Vijith Sasidhar, Prajeesh Nath, J. Abhithaj, A. Sabu, P. Rammanohar |
| 21 |
[GO] |
2020―Nov―17 |
COVID-19 pandemic crisis-a complete outline of SARS-CoV-2 |
Sana Saffiruddin Shaikh, Anooja P. Jose, Disha Anil Nerkar, Midhuna Vijaykumar KV, Saquib Khaleel Shaikh |
| 22 |
[GO] |
2020―Okt―16 |
Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach |
Kalirajan Rajagopal, Potlapati Varakumar, Aparma Baliwada, Gowramma Byran |
